Plain-English translation of NCT06591806 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study — meaning researchers will monitor your eye health over time rather than test a new medication. The study focuses on Stargardt disease, a genetic eye condition that affects your central vision. By tracking how your eyes change, researchers hope to better understand what influences disease progression and prepare for future treatments.
Stargardt disease varies from person to person, and doctors don't yet fully understand which factors predict how quickly someone's vision will decline. This study aims to fill that gap by carefully following patients over time, which will help researchers design better clinical trials and treatment options in the future.
You will attend regular visits at one of several study centers where researchers will perform eye exams and tests to monitor your vision and track how your Stargardt disease is progressing. These visits will happen over a period of time as part of a long-term follow-up study. Your doctors will gather information about your eye health but will not be testing a new treatment — they are simply observing and documenting how your condition evolves.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
United States
Norway
Sponsor
AAVantgarde Bio Srl
Enrollment target
~80 participants
Started
May 2024
Primary completion
June 2027
Age range
8 Years – 50 Years
Last updated on clinicaltrials.gov in June 2026.